During the past decade, Nemocnica A.Lena Humenne, n.o conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nemocnica A.Lena Humenne, n.o" are "Ulcerative Colitis" (2 trials), "Crohn Disease" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Nemocnica A.Lena Humenne, n.o" in a lesser frequency.

Most popular intervention types in "Nemocnica A.Lena Humenne, n.o" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "Placebo" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Etrolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnica A.Lena Humenne, n.o" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnica A.Lena Humenne, n.o". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nemocnica A.Lena Humenne, n.o, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnica A.Lena Humenne, n.o, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".